NM_153033.5:c.-44C>T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_153033.5(KCTD7):c.-44C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.467 in 1,475,286 control chromosomes in the GnomAD database, including 165,115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_153033.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD7 | NM_153033.5 | c.-44C>T | 5_prime_UTR_variant | Exon 1 of 4 | ENST00000639828.2 | NP_694578.1 | ||
KCTD7 | NM_001167961.2 | c.-44C>T | 5_prime_UTR_variant | Exon 1 of 5 | NP_001161433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCTD7 | ENST00000639828 | c.-44C>T | 5_prime_UTR_variant | Exon 1 of 4 | 2 | NM_153033.5 | ENSP00000492240.1 | |||
ENSG00000284461 | ENST00000503687.2 | n.-44C>T | non_coding_transcript_exon_variant | Exon 1 of 13 | 2 | ENSP00000421074.1 | ||||
ENSG00000284461 | ENST00000503687.2 | n.-44C>T | 5_prime_UTR_variant | Exon 1 of 13 | 2 | ENSP00000421074.1 |
Frequencies
GnomAD3 genomes AF: 0.506 AC: 76568AN: 151462Hom.: 20306 Cov.: 31
GnomAD3 exomes AF: 0.429 AC: 40765AN: 94916Hom.: 8971 AF XY: 0.424 AC XY: 22512AN XY: 53082
GnomAD4 exome AF: 0.462 AC: 612215AN: 1323718Hom.: 144781 Cov.: 32 AF XY: 0.458 AC XY: 299366AN XY: 652930
GnomAD4 genome AF: 0.506 AC: 76639AN: 151568Hom.: 20334 Cov.: 31 AF XY: 0.499 AC XY: 36984AN XY: 74072
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 63. Only high quality variants are reported. -
Progressive myoclonic epilepsy type 3 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at